Cargando…

Characterization of THSD7A-antibodies not binding to glomerular THSD7A in a patient with diabetes mellitus but no membranous nephropathy

Membranous nephropathy (MN) is an autoimmune disease caused by autoantibodies against the podocyte antigens phospholipase A(2) receptor 1 (PLA(2)R1) and thrombospondin type 1 domain containing protein 7A (THSD7A) in 80% and 2–3% of patients, respectively. THSD7A antibodies are considered to be patho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reinhard, Linda, Thomas, Cindy, Machalitza, Maya, Lattwein, Erik, Weiss, Lothar S., Vitu, Jan, Wiech, Thorsten, Stahl, Rolf A. K., Hoxha, Elion
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355258/ https://www.ncbi.nlm.nih.gov/pubmed/34376704 http://dx.doi.org/10.1038/s41598-021-94921-y

Ejemplares similares

An update on clinical significance of use of THSD7A in diagnosing idiopathic membranous nephropathy: a systematic review and meta-analysis of THSD7A in IMN
por: Ren, Song, et al.
Publicado: (2018)

THSD7A Positivity Is Associated with High Expression of FAK in Prostate Cancer
por: Flockerzi, Fidelis Andrea, et al.
Publicado: (2023)

A Novel Insight into the Role of PLA2R and THSD7A in Membranous Nephropathy
por: Zhang, Pingna, et al.
Publicado: (2021)

Meta‐Analysis of the Diagnostic Efficiency of THSD7A‐AB for the Diagnosis of Idiopathic Membranous Nephropathy
por: Liu, Yipeng, et al.
Publicado: (2020)

Expression of THSD7A in neoplasm tissues and its relationship with proteinuria
por: Xian, Li, et al.
Publicado: (2019)

Diagnostic performance of glomerular PLA2R and THSD7A antibodies in biopsy confirmed primary membranous nephropathy in South Africans
por: Lwezaula, Bingileki F, et al.
Publicado: (2021)

A rare case of PLA2R- and THSD7A-positive idiopathic membranous nephropathy
por: Wanderley, David Campos, et al.
Publicado: (2019)

Case Report: THSD7A-Positive Membranous Nephropathy Caused by Tislelizumab in a Lung Cancer Patient
por: Chen, Minjiang, et al.
Publicado: (2021)

Membranous nephropathy associated with thrombospondin type-1 domain-containing 7A (THSD7A) in an adult woman with eosinophilia
por: Shirai, Sayuri, et al.
Publicado: (2019)

Tissue staining for THSD7A in glomeruli correlates with serum antibodies in primary membranous nephropathy: a clinicopathological study
por: Sharma, Shree G, et al.
Publicado: (2018)

Thrombospondin Type 1 Domain-Containing 7A (THSD7A)-Associated Membranous Nephropathy Leading to Metastatic Neuroendocrine Carcinoma
por: Juarez, Angel, et al.
Publicado: (2023)

THSD7B Mutation Induces Platinum Resistance in Small Cell Lung Cancer Patients
por: Yao, Zifu, et al.
Publicado: (2022)

Autoantigens PLA2R and THSD7A in membranous nephropathy share a common epitope motif in the N-terminal domain
por: Fresquet, M., et al.
Publicado: (2020)

Soluble THSD7A Is an N-Glycoprotein That Promotes Endothelial Cell Migration and Tube Formation in Angiogenesis
por: Kuo, Meng-Wei, et al.
Publicado: (2011)

THSD7A staining of membranous glomerulopathy in clinical practice reveals cases with dual autoantibody positivity
por: Larsen, Christopher P, et al.
Publicado: (2016)

The Alternative Pathway Is Necessary and Sufficient for Complement Activation by Anti-THSD7A Autoantibodies, Which Are Predominantly IgG4 in Membranous Nephropathy
por: Manral, Pallavi, et al.
Publicado: (2022)

Expression, prognosis and functional role of Thsd7a in esophageal squamous cell carcinoma of Kazakh patients, Xinjiang
por: Hou, Zhichao, et al.
Publicado: (2017)

THSD7A Positivity Predicts Poor Survival and Is Linked to High FAK Expression and FGFR1-Wildtype in Female Patients with Squamous Cell Carcinoma of the Lung
por: Flockerzi, Fidelis Andrea, et al.
Publicado: (2023)

Identification of THSD7B and PRMT9 mutations as risk factors for familial lung adenocarcinoma: A case report
por: Zhang, Qianqian, et al.
Publicado: (2023)

Motor neuron-derived Thsd7a is essential for zebrafish vascular development via the Notch-dll4 signaling pathway
por: Liu, Lawrence Yu-Min, et al.
Publicado: (2016)

Role of Serum and Urine Biomarkers (PLA(2)R and THSD7A) in Diagnosis, Monitoring and Prognostication of Primary Membranous Glomerulonephritis
por: Maifata, Sadiq Mu’azu, et al.
Publicado: (2020)

The Role of Anti-PLA(2)R and Anti-THSD7A Antibodies in the Pathogenesis and Diagnostics of Primary Membranous Nephropathy: A Review of Current Knowledge for Clinical Practice
por: Smarz-Widelska, Iwona, et al.
Publicado: (2022)

Histological transition from minimal change disease to THSD7A-associated membranous nephropathy in a patient receiving long-term steroid treatment: A case report
por: Kojima, Aki, et al.
Publicado: (2023)

Integrated analysis of single-cell and bulk RNA-sequencing data reveals the prognostic value and molecular function of THSD7A in gastric cancer
por: Shen, Kaiyu, et al.
Publicado: (2023)

SNP rs3803264 polymorphisms in THSD1 and abnormally expressed mRNA are associated with hemorrhagic stroke
por: Chen, Changying, et al.
Publicado: (2023)

Role of phospholipase A(2) receptor 1 antibody level at diagnosis for long-term renal outcome in membranous nephropathy
por: Mahmud, Maida, et al.
Publicado: (2019)

Pathogenic variants in THSD4, encoding the ADAMTS-like 6 protein, predispose to inherited thoracic aortic aneurysm
por: Elbitar, Sandy, et al.
Publicado: (2020)

Membranous Nephropathy: The Journey Continues …
por: Hoxha, Elion, et al.
Publicado: (2015)

Rituximab Induces Complete Remission of Proteinuria in a Patient With Minimal Change Disease and No Detectable B Cells
por: Webendörfer, Maximilian, et al.
Publicado: (2021)

A New Chemiluminescence Immunoassay for Phospholipase A(2) Receptor 1 Autoantibodies Allows Early Identification of Autoantibody Recurrence in Patients With Membranous Nephropathy
por: Hoxha, Elion, et al.
Publicado: (2021)

Antigen-Specific IgG Subclasses in Primary and Malignancy-Associated Membranous Nephropathy
por: von Haxthausen, Franziska, et al.
Publicado: (2018)

PLA(2)R Antibody Levels and Clinical Outcome in Patients with Membranous Nephropathy and Non-Nephrotic Range Proteinuria under Treatment with Inhibitors of the Renin-Angiotensin System
por: Hoxha, Elion, et al.
Publicado: (2014)

Perspectives in membranous nephropathy
por: Tomas, Nicola M., et al.
Publicado: (2021)

Successful treatment of PLA(2)R1-antibody positive membranous nephropathy with ocrelizumab
por: Schmidt, Tilman, et al.
Publicado: (2020)

Complement catalyzing glomerular diseases
por: Zipfel, Peter F., et al.
Publicado: (2021)

Complement Inhibitors in Clinical Trials for Glomerular Diseases
por: Zipfel, Peter F., et al.
Publicado: (2019)

Erfahrungen aus dem deutschen COVID-19-Register
por: Hoxha, Elion
Publicado: (2020)

Update zu: Erfahrungen aus dem deutschen COVID-19-Register
por: Hoxha, Elion
Publicado: (2021)

A Genetic Risk Score Distinguishes Different Types of Autoantibody-Mediated Membranous Nephropathy
por: Gupta, Sanjana, et al.
Publicado: (2023)

Role of Glomerular Proteoglycans in IgA Nephropathy
por: Ebefors, Kerstin, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_gpvfbq547eoeujggdssc8d64q5